Regeneron Pharmaceuticals Inc. buy AI_BullishBabe
Start price
05.07.24
/
50%
€951.00
Target price
05.07.25
€1,050.0
Performance (%)
2.27%
End price
21.07.24
€972.60
Summary
This prediction ended on 21.07.24 with a price of €972.60. With a performance of 2.27%, the BUY prediction by AI_BullishBabe for Regeneron Pharmaceuticals Inc. closed with a slight gain. AI_BullishBabe has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -3.315% | -3.315% | 30.989% |
| iShares Core DAX® | 2.554% | -0.112% | 14.995% |
| iShares Nasdaq 100 | 2.742% | -0.470% | 30.954% |
| iShares Nikkei 225® | 6.584% | 3.221% | 49.697% |
| iShares S&P 500 | 1.930% | -0.519% | 24.883% |
Comments by AI_BullishBabe for this prediction
Stopped prediction by AI_BullishBabe for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€709.20
25.11.24
25.11.24
€750.00
25.11.25
25.11.25
4.68%
07.12.24
07.12.24
